[{"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215037"], "brand_name": ["NELARABINE"], "generic_name": ["NELARABINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1726"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NELARABINE"], "rxcui": ["603566"], "spl_id": ["b3627acf-0207-443a-8e5a-0b4ad974715a"], "spl_set_id": ["e425731e-626b-4141-a997-fb85e077c2a4"], "package_ndc": ["70710-1726-1", "70710-1726-8"], "is_original_packager": [true], "upc": ["0370710172619"], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["60158CV180"]}, "product_type": "Drugs", "event_id": "96291", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0255-2025", "product_description": "Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1726-1;  b) 6 x 50 mL Single-Dose Vial, NDC 70710-1726-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ", "product_quantity": "36,978 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250213", "center_classification_date": "20250306", "report_date": "20250312", "code_info": "Lot: a) P300072, P300073 Exp. Feb-2025; P300153, Exp. Jun-25; P300195, Exp. Aug-2025; P400014, P400017, Exp. Dec-2025; P400070, Exp. Feb-2026; P400112, May-2026; P400142, Exp. Jul-2026; b) P300068, Exp. Feb-2025; P300154, Exp.Jun-2025; P400015, P400018, Exp. Dec-2025; P400068, Exp. Feb-2026; P400114, Exp. May-2026; P400139, Exp.Jul-2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091643"], "brand_name": ["FINASTERIDE"], "generic_name": ["FINASTERIDE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FINASTERIDE"], "rxcui": ["200172"], "spl_id": ["2397604d-3fd8-2d97-e063-6394a90a0750"], "spl_set_id": ["e3728709-e805-4b46-9954-2c433a865987"], "package_ndc": ["16729-089-10", "16729-089-15"], "is_original_packager": [true], "upc": ["0316729089104", "316729089104", "316729089159"], "nui": ["N0000175836", "N0000000126"], "pharm_class_epc": ["5-alpha Reductase Inhibitor [EPC]"], "pharm_class_moa": ["5-alpha Reductase Inhibitors [MoA]"], "unii": ["57GNO57U7G"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0390-2023", "product_description": "Finasteride Tablets USP, 1 mg, Rx Only, Packaged as:  a) 30-count bottle NDC 16729-089-10 UPC 3 16729 08910 4; b) 90-count bottle NDC 16729-089-15 UPC 3 16729 08915 9; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA", "product_quantity": "325,356 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2005979, Exp. Date 10/31/2023; P2100252, Exp. Date 12/31/2023; P2101710, Exp. Date 2/29/2024;  b) P2100253, Exp. Date 12/31/2023;  P2103035, Exp. Date 4/30/2024; P2103036, Exp. Date 4/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0551-2022", "product_description": "Back Relief II (Acetaminophen 200 mg, Magnesium Salicylate 200 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-740-00", "product_quantity": "1,477,641 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M740LA  Bulk Lots: 19C022, 19C023"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-001", "product_description": "Amlodipine Besylate Tablets, USP, 2.5 mg, packaged in a) 90-count bottles (NDC 0378-5208-77) and b) 500-count bottles (NDC 0378-5208-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "37,752 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot #: a) 3037907, 3040106; b) 3037907, 3040106, 3044357"}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0717-2018", "product_description": "CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "745 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lot: C/010218 Discard by 07/01/2018; CAC/013118 Discard by 4/1/2018; CAC/020518 Discard by 4/6/2018; CAC/021418 Discard by 4/15/2018"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0955-2023", "product_description": "vancomycin 1.25 g/250 mL added to 0.9% Sodium Chloride, 5 mg/mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6074-1", "product_quantity": "15,304  bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254431, Exp. 9/5/2023; 36-255125, 36-255126, 36-255127, Exp. 9/6/2023; 36-248083 Exp. 8/10/2023; 36-238973, 36-238980, Exp. 7/10/2023; 36-239520, Exp. 7/12/2023; 36-240087, Exp. 7/13/2023; 36-248979, 36-248980, 36-248981, Exp. 8/16/2023; 36-240760, 36-240761, 36-240762, Exp. 7/17/2023; 36-240837, 36-240838, Exp. 7/18/2023; 36-241131, 36-241132, Exp. 7/19/2023; 36-241436, Exp. 7/20/2023; 36-251065, Exp. 8/24/2023; 36-241980, Exp. 7/24/2023; 36-242707, Exp. 7/26/2023; 36-243153, 36-243155, 36-243156, Exp. 7/27/2023; 36-252188, 36-252189, 36-252191, 36-252192, 36-252198, 36-252201, Exp. 8/31/2023; 36-243951, Exp. 7/31/2023."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0241-2025", "product_description": "Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-758-01.", "product_quantity": "233,040 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232540, 19232524, 19232553, Exp.: 5/2025; 19240510, Exp.: 1/2026; 19241489, Exp.: 3/2026; 19243905, 19243935, Exp.: 9/2026."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-862-2015", "product_description": "Primaquine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1985 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0035-2023", "product_description": "LIDOCAINE/PHENYLEPHRINE PF SYR 1%/1.5% Solution, 3 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "389 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65972, BUD: 10/27/2022"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078765"], "brand_name": ["FOSPHENYTOIN SODIUM"], "generic_name": ["FOSPHENYTOIN SODIUM"], "manufacturer_name": ["West-Ward Pharmaceuticals Corp"], "product_ndc": ["0143-9782", "0143-9788"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["6b56fe59-9fb1-410b-b57c-7ada1662136a"], "spl_set_id": ["c92df63b-5140-4213-8d43-8327ff6230b7"], "package_ndc": ["0143-9788-01", "0143-9788-25", "0143-9782-01", "0143-9782-10", "0143-9704-25"], "is_original_packager": [true], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "62627", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "All lots were distributed throughout the US.", "recall_number": "D-1437-2012", "product_description": "Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ  07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).", "product_quantity": "a) 308,275 vials; b) 2,008,850 vials", "reason_for_recall": "Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.", "recall_initiation_date": "20120413", "center_classification_date": "20120802", "termination_date": "20150116", "report_date": "20120808", "code_info": "Lot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["RAPIDOL ARNICA"], "generic_name": ["ARNICA MONTANA"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-405"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ARNICA MONTANA"], "spl_id": ["2734f895-0036-187d-e063-6394a90a20f6"], "spl_set_id": ["051ec8dc-02cf-e8f7-e063-6294a90a378e"], "package_ndc": ["55758-405-99"], "is_original_packager": [true], "unii": ["O80TY208ZW"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0383-2025", "product_description": "Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-405-99", "product_quantity": "6,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: EAT-01, EXP: MAR 27"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0621-2016", "product_description": "CEFTRIAXONE in NS, Packaged as a) 1GM in 50ML Homepumps, b) 2GM in 100ML Homepumps, and c) 8GM in 200ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a) 8 Bags, b) 70 Bags c) 4 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 26-Sep-15, 27-Sep-15, b) 21-Sep-15, 24-Sep-15, 25-Sep-15, 26-Sep-15, 27-Sep-15, c) 25-Sep-15"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66172", "recalling_firm": "Medaus, Inc.", "address_1": "6801 Cahaba Valley Rd Ste 116", "address_2": "N/A", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1048-2013", "product_description": "Testosterone Cyp 200 mg/mL, W/Pres. (Benzyl ETOH), 3 mL, Medaus pharmacy 1-800-526-9183", "product_quantity": "1198 mL", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140716", "report_date": "20130925", "code_info": "LOT # 130508-1, BUD: 11/16/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0177-2015", "product_description": "AVASTIN, 1.25mg/0.5mL, injectable, 0.05 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "5483/0.5 mL syringes", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140715@13, discard date: 11/3/2014;  Lot #: 20140716@25, discard date: 10/14/2014;  Lot #: 20140717@7, discard date: 10/15/2014;  Lot #: 20140724@14, discard date: 10/22/2014;  Lot #: 20140724@15, discard date: 10/22/2014;  Lot #: 20140729@11, discard date: 10/27/2014;  Lot #: 20140801@17, discard date: 10/30/2014;  Lot #: 20140805@1, discard date: 11/3/2014;  Lot #: 20140807@13, discard date: 11/5/2014;  Lot #: 20140811@30, discard date: 11/9/2014;  Lot #: 20140813@10, discard date: 11/11/2014;  Lot #: 20140825@8, discard date: 11/23/2014;  Lot #: 20140904@46, discard date: 12/3/2014;  Lot #: 20140909@12, discard date: 12/8/2014;  Lot #: 20140909@21, discard date: 12/8/2014;  Lot #: 20140912@30, discard date: 12/11/2014;  Lot #: 20140917@11, discard date: 12/16/2014;  Lot #: 20140917@9, discard date: 12/16/2014;  Lot #: 20140922@30, discard date: 12/21/2014;  Lot #: 20140814@15, discard date: 11/12/2014."}, {"status": "Ongoing", "city": "Kennett Square", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97202", "recalling_firm": "Boothwyn Pharmacy LLC", "address_1": "221 Gale Ln", "address_2": "N/A", "postal_code": "19348", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0609-2025", "product_description": "Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy", "product_quantity": "648 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250709", "center_classification_date": "20250829", "report_date": "20250910", "code_info": "03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64106", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA", "recall_number": "D-174-2013", "product_description": "Isoniazid Tablets 300 mg tablets USP, Rx Only, a) 30 tablets - NDC 61748-013-30, b) 100 tablets - NDC  61748-013-01, Mfd for: VersaPharm Incorporated Marietta, GA 30065-1505, Mfd by: West - Ward Pharmaceutical Corp.., Eatontown, NJ 07724", "product_quantity": "77531 bottles", "reason_for_recall": "Failed Dissolution Specifications; 36 month stability timepoint", "recall_initiation_date": "20121204", "center_classification_date": "20130227", "termination_date": "20140114", "report_date": "20130306", "code_info": "67079A; 67079B; 67079C"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81936", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0389-2019", "product_description": "Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count  bottles, Rx only, Manufactured by: Teva  Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10", "product_quantity": "118 bottles", "reason_for_recall": "Presence of Foreign Substance: Product complaint of black speckles observed on tablets.", "recall_initiation_date": "20190115", "center_classification_date": "20190122", "termination_date": "20200303", "report_date": "20190130", "code_info": "Lot #: 43E021 and 43E023, Exp. 01/2020"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-858-2015", "product_description": "Prednisone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0563-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Eye Stress, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955515128, NDC 57955-5151-2", "product_quantity": "198 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 033116P Exp. 03/19; 110916B Exp. 11/19"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016733"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-2201"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["35e26a6d-60d6-4388-84e9-c481a3b69ee7"], "spl_set_id": ["0d59a04a-32e6-485b-b638-a1e6c09e9642"], "package_ndc": ["0264-2201-00", "0264-2201-10", "0264-2201-50", "0264-2201-70"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "79348", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "N/A", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0549-2018", "product_description": "0.9% Sodium Chloride Irrigation USP, 1000 mL Plastic Irrigation Container (PIC), Rx only, B. Braun Medical Inc., Irvine, CA  92614, Catalog # R5200-01, NDC 0264-2201-00.", "product_quantity": "17,360 plastic irrigation containers", "reason_for_recall": "Presence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to manufacture the container cap was received.", "recall_initiation_date": "20180216", "center_classification_date": "20180227", "termination_date": "20200123", "report_date": "20180307", "code_info": "Batch # J7N912, Exp 10/31/20"}, {"country": "United States", "city": "North Blenheim", "address_1": "119 Creamery Road", "reason_for_recall": "cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure", "address_2": "", "product_quantity": "50 bottles", "code_info": "Lot BP18181301, Exp. Date  02/29/2016", "center_classification_date": "20150528", "distribution_pattern": "Indiana", "state": "NY", "product_description": "Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Repackaged By: Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-522-20, MFG: 64679-904-02", "report_date": "20150603", "classification": "Class II", "openfda": {}, "recalling_firm": "Blenheim Pharmacal, Inc.", "recall_number": "D-1110-2015", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "71331", "termination_date": "20160115", "more_code_info": "", "recall_initiation_date": "20150522", "postal_code": "12131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65501", "recalling_firm": "Sun Pharmaceutical Industries Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-687-2013", "product_description": "Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.", "product_quantity": "46387 Cartons", "reason_for_recall": "Crystallization; crystallized nimodipine", "recall_initiation_date": "20130521", "center_classification_date": "20130708", "termination_date": "20140825", "report_date": "20130717", "code_info": "Lot #s: a) 3305.036B, 3305.037B, Exp Jun-13; 3505.041B, Exp Sep-13; 3305.043B, Exp Nov-13; 3305.044B, Exp Dec-13; 3305.045B  Mar-14.    Lot #s: b) 3305.036A, 3305.037A, Exp Jun-13; 3305.038A, Exp Jul-13;  3305.040A,  3505.041A Exp Sep-13; 3305.042A, 3305.043A, Exp Nov-13; 3305.044A  Dec-13."}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1369-2022", "product_description": "Hydrogen Peroxide 16 fl. oz. and 32 oz. bottles distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 909221, 901675", "more_code_info": ""}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029288 Exp. 11/14/2019,    10029762 Exp. 11/14/2019,  10029788 Exp. 11/18/2019,  10029838 Exp. 11/19/2019,  10029948 Exp. 11/21/2019,  10029949 Exp. 11/21/2019,  10030337 Exp. 11/24/2019,  10029838 Exp. 11/19/2019,  10030539 Exp. 11/28/2019,  10030943 Exp. 12/3/2019,  10030964 Exp. 12/3/2019,  10030963 Exp. 12/3/2019,  10030964 Exp. 12/3/2019,  10030888 Exp. 12/2/2019,  10030963 Exp. 12/3/2019,  10031129 Exp. 12/8/2019,  10031284 Exp. 12/11/2019,  10031414 Exp. 12/15/2019,  10031435 Exp. 12/16/2019,  10031735 Exp. 12/22/2019,  10032253 Exp. 12/30/2019,  10030455 Exp. 11/26/2019,  10032535 Exp. 1/6/2020,  10032280 Exp. 12/31/2019,  10030455 Exp. 11/26/2019,  10032535 Exp. 1/6/2020,    10033009 Exp. 1/15/2020,  10032585 Exp. 1/14/2020,  10033009 Exp. 1/15/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 500 mcg/250 mL (2 mcg/mL) BUPivacaine HCl 0.0625% 156.25 mg/250 mL (0.625 mg/mL) in 0.9% Sodium Chloride in 250 mL Bag, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1269-37", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0549-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-033-2014", "product_description": "Alprostadil 40mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0106-2020", "product_description": "Cyclopentolate HCl 1% (5 mg/0.5 mL) / Phenylephrine HCl 2.5% (12.5 mg/0.5 mL) / Tropicamide 1% (5 mg/0.5 mL) / Ketorolac Tromethamine 0.5% (2.5 mg/0.5 mL), Sterile Ophthalmic Topical Solution, 0.5 mL Fill in 3 mL Syringe,  Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321677510", "product_quantity": "1815 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "3", "code_info": "B3727 Exp 12/27/13, C5511 Exp 9/5/13, and L5312 Exp 11/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-708-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211884"], "brand_name": ["SUCRALFATE"], "generic_name": ["SUCRALFATE"], "manufacturer_name": ["VistaPharm, LLC"], "product_ndc": ["66689-305"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUCRALFATE"], "rxcui": ["313123"], "spl_id": ["f133ac10-0969-47cb-932a-7b100b05105c"], "spl_set_id": ["cbfbe146-5d42-4a55-9050-df2b5581487a"], "package_ndc": ["66689-305-16"], "is_original_packager": [true], "upc": ["0366689305165"], "nui": ["N0000175801", "M0015420"], "pharm_class_epc": ["Aluminum Complex [EPC]"], "pharm_class_cs": ["Organometallic Compounds [CS]"], "unii": ["XX73205DH5"]}, "product_type": "Drugs", "event_id": "93096", "recalling_firm": "VistaPharm LLC", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0047-2024", "product_description": "Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16", "product_quantity": "180 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.", "recall_initiation_date": "20231018", "center_classification_date": "20231016", "termination_date": "20240430", "report_date": "20231025", "code_info": "Lot#: 810300, Exp 10/2023"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-121-2014", "product_description": "HCG 220 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "4797 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-675-2013", "product_description": "Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "13ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCACBA:23, Exp date: 3/31/2013 and Lot number CABDAIAD:13, Exp date: 9/4/2013."}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1476-2020", "product_description": "Tasty Drops, Hemp Oil Extract, Vanilla, 500MG CBD, 1 FL. OZ (30ML) bottles, Dist by: Tasty Hemp Oil, Jenison, MI, UPC 6 96305 29082 8", "product_quantity": "152 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003140, FG003182, FG003246", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89326", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Methylprednisolone, TN Norepinephrine BItartrate - MS, OH", "recall_number": "D-0371-2022", "product_description": "Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0703-1153-03.", "product_quantity": "11,450 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211231", "center_classification_date": "20220113", "termination_date": "20240604", "report_date": "20220119", "code_info": "Lot # 100020800, exp 07/2022"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0780-2018", "product_description": "Temozolomide 20 mg NDC 43975-0253-05 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0217-2021", "product_description": "Ketamine 50 mg/5mL in 0.9% Sodium Chloride Injection (10 mg/mL), CII, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004043009", "product_quantity": "9942 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023040, BUD 1/19/2021;  1220023070, BUD 1/21/2021;  1220023105, BUD 1/25/2021;  1220023158, BUD 1/26/2021;  1220023315, BUD 2/1/2021;  1220023342, BUD 2/2/2021;  1220023431, BUD 2/4/2021;  1220023471, BUD 2/3/2021;  1220023481, BUD 2/4/2021 &  1220023509, BUD 2/8/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0171-2019", "product_description": "Phenol 7% and Glycerin Aqueous Solution 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1432-10", "product_quantity": "630 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08082018:86 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1212-2020", "product_description": "Bi-Est (1:1)/Progesterone/Testosterone 2.0 mg/40 mg/1.0 mg/mL Cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44892 Discard by: 4/15/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022057"], "brand_name": ["ENDOMETRIN"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Ferring Pharmaceuticals Inc."], "product_ndc": ["55566-6500"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["VAGINAL"], "substance_name": ["PROGESTERONE"], "rxcui": ["725094", "725098"], "spl_id": ["8749cf61-2e35-473a-bfe5-49d342a17ff3"], "spl_set_id": ["2ba50fa9-b349-40cb-9a4b-1af8faa4ec09"], "package_ndc": ["55566-6500-1", "55566-6500-2", "55566-6500-3"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "66604", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "4 Gatehall Dr Fl 3rd", "address_2": "", "postal_code": "07054-4518", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1426-2014", "product_description": "ENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054 ---- NDC 55566-6500-3", "product_quantity": "72,046 cartons", "reason_for_recall": "Discoloration; due to prolonged heat exposure.", "recall_initiation_date": "20130919", "center_classification_date": "20140709", "termination_date": "20150219", "report_date": "20140716", "code_info": "Lot Number:Expiry Date - 0804.182B-1:07/14; 0804.183B-1:07/14; 0804.185A-1:08/14; 0804.186B-1:08/14; 0804.187B-1:08/14; 0804.210A-1:12/14; 0804.212A-1:12/14; 0804.213A-1:12/14; 0804.214A-1:12/14; 0804.216B-1:12/14; 0804.223B-1:02/15 0804.225B-1:03/15", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0102-2022", "product_description": "ALPROSTADIL 30MCG/ML INJ  30MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "3 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06142021:35 BUD: 10/23/2021; 07282021:49 BUD: 01/24/2022; 08302021:48 BUD: 02/26/2022", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Testost CYP 200mg/mL SUS, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0458-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0219-2020", "product_description": "S-ESTRADIOL VALERATE 20MG/ML MDV INJ IN ETHYL OLEATE, packaged in a) 5ml, b) 10ml, glass vial, RX Only, Red Mountain Compounding RX.", "product_quantity": "2x5ml, 1x10 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S07232019DH@10, Exp 10/23/19; S08012019DH@03, Exp 11/1/19;"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA211980"], "brand_name": ["NOREPINEPHRINE BITARTRATE"], "generic_name": ["NOREPINEPHRINE BITARTRATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-615"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NOREPINEPHRINE BITARTRATE"], "rxcui": ["242969"], "spl_id": ["4bb42f07-a41e-42f3-92e7-dab665584f84"], "spl_set_id": ["4bb42f07-a41e-42f3-92e7-dab665584f84"], "package_ndc": ["47335-615-44", "47335-615-40"], "is_original_packager": [true], "unii": ["IFY5PE3ZRW"]}, "product_type": "Drugs", "event_id": "91983", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "N/A", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0529-2023", "product_description": "Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-40); packaged in 10 x 4 mL Single-dose Fliptop Vials per carton (NDC 47335-615-44); Rx only, Manufactured by: Gland Pharma Limited, Hyderabad-502307 India; Distributed by: Sun Phamaceutical Industries, Inc., Cranbury, NJ 08512.", "product_quantity": "16,450 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.", "recall_initiation_date": "20230329", "center_classification_date": "20230410", "termination_date": "20231031", "report_date": "20230419", "code_info": "Lot Number: G1510001, Exp 11/2023; G151002, Exp. 12/2023; and G151003, Exp 02/2024"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021879"], "brand_name": ["NUEDEXTA"], "generic_name": ["DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE"], "manufacturer_name": ["Avanir Pharmaceuticals, Inc."], "product_ndc": ["64597-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROMETHORPHAN HYDROBROMIDE", "QUINIDINE SULFATE"], "rxcui": ["1040054", "1040058"], "spl_id": ["545d121c-01b2-4375-9067-52fc8ad23d74"], "spl_set_id": ["484e0918-3442-49dc-8ccf-177f1f3ee9f3"], "package_ndc": ["64597-301-13", "64597-301-60"], "is_original_packager": [true], "unii": ["9D2RTI9KYH", "J13S2394HE"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0442-2021", "product_description": "Nuedexta (dextromethorphan HBr and quinidine sulfate) Capsules 20 mg/10 mg 60 capsules Rx only NDC 64597-301-60 Manufactured by Patheon, Inc. Whitby, ON L1N 5Z5, Canada", "product_quantity": "255 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "CFBFP"}, {"status": "Terminated", "city": "Caguas", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76020", "recalling_firm": "Mylan LLC.", "address_1": "Road #156, Km. 58.8, Lot 24B", "address_2": "N/A", "postal_code": "00725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0442-2017", "product_description": "Temozolomide Capsules, 140 mg, packaged in a) 5-count bottles (NDC 0378-5263-98), b) 14-count bottles (NDC 0378-5263-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.", "product_quantity": "a) 746 bottles (lot 2006903); b)588 bottles (lot 2006902)", "reason_for_recall": "Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.", "recall_initiation_date": "20161220", "center_classification_date": "20170125", "termination_date": "20180125", "report_date": "20170201", "code_info": "LOT #: a) 2006903, Exp 02/18; b) 2006902, Exp 02/18"}, {"status": "Terminated", "city": "Maple Grove", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209916"], "brand_name": ["BUMETANIDE"], "generic_name": ["BUMETANIDE"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-0540", "0832-0541", "0832-0542"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUMETANIDE"], "rxcui": ["197417", "197418", "197419"], "spl_id": ["d53166d9-64ca-4b76-81a7-b70a60c53b12"], "spl_set_id": ["ff5dc8c6-b2f2-41d3-8e56-a953aa721b59"], "package_ndc": ["0832-0540-11", "0832-0541-11", "0832-0541-10", "0832-0542-11", "0832-0542-10"], "is_original_packager": [true], "upc": ["0308320540115", "0308320541112"], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["0Y2S3XUQ5H"]}, "product_type": "Drugs", "event_id": "81174", "recalling_firm": "Upsher Smith Laboratories, Inc.", "address_1": "6701 Evenstad Dr N", "address_2": "N/A", "postal_code": "55369-6026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico and Guam", "recall_number": "D-0280-2019", "product_description": "Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by:  Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11", "product_quantity": "44,764 bottles", "reason_for_recall": "Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.", "recall_initiation_date": "20180919", "center_classification_date": "20181121", "termination_date": "20200930", "report_date": "20181031", "code_info": "Lot#:  375716, Exp 4/30/2020; 372957, 372958, 372959, Exp 3/31/2020; 374541, 375717, 376688, Exp 5/31/2020"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NIACIN TR, Tablet, 1000 mg may have potentially been mislabeled as the following drug:  NIACIN TR, Tablet, 750 mg, NDC 00536703301, Pedigree: AD46414_56, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "NIACIN TR, Tablet, 1000 mg has the following codes:   Pedigree: AD46414_50, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NIACIN TR, Tablet, 1000 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536703801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-945-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0529-2017", "product_description": "BICARBONATE 10%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg) may have potentially been mislabeled as the following drug:   traMADol HCl, Tablet, 25 mg (1/2 of 50 mg), NDC 57664037708, Pedigree: AD60272_92, EXP: 5/22/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg) has the following codes:   Pedigree: AD60243_1, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591024001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-960-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0914-2019", "product_description": "NET Remedies #12 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "2100 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-101116C Exp. 10/19; AUS-050916A Exp. 05/19; AUS-030917E Exp. 03/20; AUS-011916M Exp. 01/19; AUS091515K Exp. 09/18; AUS-030816L Exp. 03/19"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["HEALTHWISE MENSTRUAL PAIN RELIEF PATCH"], "generic_name": ["MENTHOL"], "manufacturer_name": ["Veridian Healthcare"], "product_ndc": ["71101-947"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MENTHOL, UNSPECIFIED FORM"], "rxcui": ["2621715"], "spl_id": ["29922bcf-4924-bc88-e063-6294a90a3002"], "spl_set_id": ["ee62e44e-a09f-2e58-e053-2a95a90abe04"], "package_ndc": ["71101-947-10"], "is_original_packager": [true], "unii": ["L7T10EIP3A"], "upc": ["845717010726"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0067-2025", "product_description": "HealthWise PERIOD PATCH Menstrual Pain Relief, Menthol 10%, 10 patches per box, Manufactured for Veridian Healthcare, LLC, Gurnee, IL  60031 NDC 71101-947-10, UPC 8 45717 01072 6", "product_quantity": "10,368 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 45717 01072 6", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "13,041 cases", "code_info": "Product Code: 6414; Lots: 57847, EXP 09/18/2017; 57852, 57875, EXP 08/14/2017; 58246, EXP 09/20/2017; 58802, 58851, EXP 10/09/2017; 58924, 59091, 59116, EXP 11/03/2017; 59494, EXP 11/27/2017; 60123, EXP 01/02/2018; 60466, 60880, 60925, 01/22/2018; 61364, 03/05/2018; 61705, EXP03/30/2018; 62061, EXP 04/17/2018; 62076, EXP 04/27/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q CARE q4 Oral Cleansing & Suctioning System, Contains 1 Covered Yankauer and Y-Connector, 2 Suction Toothbrush packages with  Antiplaque solution, 4 Suction Oral Swab packages with  Antiseptic  Oral Rinse,  2 Oropharyngeal Suction Catheter packages, Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6414 UPC 6 18029 84138 4", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0375-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0103-2022", "product_description": "ALPROSTADIL 32MCG/ML  32MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08262021:68 BUD: 12/24/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71920", "recalling_firm": "GlaxoSmithKline, LLC.", "address_1": "1011 North Arendell Ave", "address_2": "N/A", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1359-2015", "product_description": "Bactroban (mupirocin calcium) Nasal Ointment, 2% 1g tube, Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC  27597-1217.  NDC 0029-1526-11", "product_quantity": "88,489 tubes", "reason_for_recall": "Penicillin Cross Contamination and Presence of Foreign Substance.  Product was contaminated with penicillin and foreign substances during manufacturing process.", "recall_initiation_date": "20150813", "center_classification_date": "20150825", "termination_date": "20170321", "report_date": "20150902", "code_info": "Lot #: C704202, Exp 11/2016; Lot #: C706532, Exp 12/2016; Lot #: C713177, Exp 1/2017; Lot #: C716567, Exp 2/2017, Lot #: C720097, C720098, Exp 3/2017, Expanded to include: C720096, Exp. 2/2017."}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200770"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-327"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905225"], "spl_id": ["29ba565b-f079-8375-e063-6394a90a83be"], "spl_set_id": ["b9117e55-9fd0-4ba2-94b4-f5f8c522d70c"], "package_ndc": ["63739-327-10", "0000127312", "0000127576", "0000127577", "0000128204", "0000128358"], "original_packager_product_ndc": ["64380-734"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "96159", "recalling_firm": "SKY PACKAGING", "address_1": "4835 Crumpler Rd Ste B", "address_2": "", "postal_code": "38141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0219-2025", "product_description": "HydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-327-10", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250124", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot #: 0000127312, Exp. Date 31-Mar-2025; 0000127576, 0000127577, Exp. Date 31-Jul-2025; 0000128204, Exp. Date 31-Dec-2025; 0000128358, Exp. Date 31-Jan-2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94554", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide", "recall_number": "D-0547-2024", "product_description": "Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. NOT FOR RESALE. OFFICE USE ONLY  Compounded by: Imprimis NJOF, LLC., 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852 NDC: 71384-514-05", "product_quantity": "136,005 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240607", "report_date": "20240619", "code_info": "Lot:23APR005  Exp. 5/1/2024  Lot:23MAY024  Exp. 5/15/2024  Lot:23JUN010  Exp. 5/30/2024  Lot:23JUN016  Exp. 6/7/2024  Lot:23JUN047  Exp. 7/4/2024  Lot:23JUL013  Exp. 7/11/2024  Lot:23JUL029  Exp. 7/25/2024  Lot:23JUL030       Exp. 8/1/2024  Lot:23AUG016  Exp. 8/7/2024  Lot:23AUG042  Exp. 9/27/2024  Lot:23SEP017  Exp. 7/13/2024  Lot:23OCT039  Exp. 8/3/2024  Lot:23NOV022  Exp. 8/24/2024  Lot:23NOV036  Exp. 8/29/2024  Lot:23DEC021  Exp. 10/4/2024  Lot:24JAN018  Exp. 10/11/2024  Lot:24JAN026  Exp. 10/24/2024  Lot:24JAN040  Exp. 11/2/2024  Lot:24FEB021  Exp. 11/16/2024  Lot:24MAR005  Exp. 12/12/2024"}, {"status": "Terminated", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72830", "recalling_firm": "Reesna, Inc", "address_1": "7921 Canoga Ave Ste I", "address_2": "N/A", "postal_code": "91304-5021", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and United Kingdom", "recall_number": "D-0960-2016", "product_description": "FUEL UP HIGH OCTANE, capsules, a) 1-count package, b) 5-count bottle, c) 10-count bottle  WWW.FUELUPPILLS.COM", "product_quantity": "7,250 capsules", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: Products were found to be tainted with undeclared hydroxythiohomosildenafil, an analogue of Sildenafil, an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making them unapproved new drugs.", "recall_initiation_date": "20151211", "center_classification_date": "20160606", "termination_date": "20160609", "report_date": "20160615", "code_info": "Exp. 12/18"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0916-2022", "product_description": "Zinc Chloride (0.5 mg/mL), Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0071-30", "product_quantity": "1291 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: K24024 BUD: 5/24/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Sunrise", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65338", "recalling_firm": "Actavis South Atlantic LLC", "address_1": "13800 Nw 2nd St Ste 190", "address_2": "N/A", "postal_code": "33325-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-829-2013", "product_description": "Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only.  Manufactured by VistaPharm, Inc., Birmingham, AL 35242.  Distributed by Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC  28092 USA", "product_quantity": "A total of 133,968 bottles (units)", "reason_for_recall": "Failed Impurity/Degradation Specification; \"Related Compound C\"", "recall_initiation_date": "20130515", "center_classification_date": "20130730", "termination_date": "20140515", "report_date": "20130807", "code_info": "Lot Numbers:  247900, 251000, 256000, 261200, 263600, 266700, 277100, 280300 and 284300.", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202033"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-4595", "0378-4596", "0378-4597", "0378-4598"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["f56f2132-0bd9-4818-a693-11b39f022bd4"], "spl_set_id": ["c50e8e36-42df-406b-8e63-eb8bf3f07e89"], "package_ndc": ["0378-4595-77", "0378-4595-10", "0378-4596-77", "0378-4596-10", "0378-4597-77", "0378-4597-10", "0378-4598-77", "0378-4598-05"], "is_original_packager": [true], "upc": ["0303784597774", "0303784598771", "0303784596777", "0303784595770"], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "68783", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0009-2015", "product_description": "Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles,  Rx only, Mfg by Mylan Pharmaceuticals, Inc. Morgantown, WV  26505. NDC 0378-4596-77.", "product_quantity": "15,966 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol", "recall_initiation_date": "20140703", "center_classification_date": "20141008", "termination_date": "20160920", "report_date": "20141015", "code_info": "Lot 3023805 Exp. 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-583-2015", "product_description": "Cidofovir Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "420 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090589"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5985", "0093-5986"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "1870207"], "spl_id": ["f96bd477-2239-4453-aaa4-e20d16c6e49e"], "spl_set_id": ["04f07f15-55e2-411b-abb8-07eab37f5664"], "package_ndc": ["0093-5986-19", "0093-5986-27", "0093-5985-19", "0093-5985-27"], "is_original_packager": [true], "upc": ["0300935985275", "0300935986272", "009359862703"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0577-2021", "product_description": "EPINEPHRINE INJECTION USP, 0.3MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS)  2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5986-27", "product_quantity": "414 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "033J20AA"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91749", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0361-2023", "product_description": "Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-301-10.", "product_quantity": "24,870 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230222", "center_classification_date": "20230227", "termination_date": "20240924", "report_date": "20230308", "code_info": "Lots: PE2029, Exp. 06/17/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Statesville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89773", "recalling_firm": "Family Pharmacy of Statesville", "address_1": "3478 E Broad St", "address_2": "N/A", "postal_code": "28625-4523", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NC only", "recall_number": "D-0657-2022", "product_description": "Hydromorphone HCl 1 mg/mL 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.", "product_quantity": "4 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200806", "center_classification_date": "20220317", "termination_date": "20230815", "report_date": "20220323", "code_info": "Lot #: 07272020@2 BUD: 10/25/2020; 07302020@1 BUD: 10/28/2020; 08012020@1 BUD: 10/30/2020"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-304-2014", "product_description": "Testosterone Pellets 25mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "107 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Charleston", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94447", "recalling_firm": "EPI Health, LLC", "address_1": "174 Meeting St Ste 200", "address_2": "N/A", "postal_code": "29401-3211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0474-2024", "product_description": "minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-101-30.", "product_quantity": "12808 bottles", "reason_for_recall": "CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.", "recall_initiation_date": "20240423", "center_classification_date": "20240425", "termination_date": "20240912", "report_date": "20240501", "code_info": "lot # T2300765- exp. 11/30/2025 lot# T2201702A-exp. 02/28/2025 lot# T2201699- exp. 2/28/2025 lot# T2201698- exp. 2/28/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077614"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-092", "68382-093", "68382-094", "68382-095"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["2e368267-8da4-4606-9348-0246a064016c"], "spl_set_id": ["dc6a2d33-aa04-4a04-9cde-901b744d24ca"], "package_ndc": ["68382-092-17", "68382-092-01", "68382-092-05", "68382-093-17", "68382-093-05", "68382-093-01", "68382-094-17", "68382-094-01", "68382-094-05", "68382-095-17", "68382-095-01", "68382-095-05"], "is_original_packager": [true], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "82714", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1273-2019", "product_description": "Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-093-05", "product_quantity": "3900", "reason_for_recall": "Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg", "recall_initiation_date": "20190425", "center_classification_date": "20190507", "termination_date": "20210629", "report_date": "20190515", "code_info": "Z804517, exp Nov 30, 2020"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0203-2020", "product_description": "S-ATROPINE 0.5% OPTH SOLN, 10 ML dropper bottle, RX only, Red Mountain Compounding RX.", "product_quantity": "1x10 ml dropper bottle", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S05232019DH@04, Exp 8/23/19"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0702-2022", "product_description": "Gentamicin Sulfate Cream USP, 0.1%, packaged in 30 grams tubes, Rx Only, Manufactured for: SOLA Pharmaceuticals, LLC, Baton Rouge, LA 70810, NDC 70512-036-30.", "product_quantity": "31,489 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15725, Exp. 6/30/2022; 16113, Exp. 10/31/2022"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77659", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0998-2017", "product_description": "Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02", "product_quantity": "844 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.", "recall_initiation_date": "20170628", "center_classification_date": "20170714", "termination_date": "20180116", "report_date": "20170726", "code_info": "Lot #: 2578400, 0Exp 8/2019"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Lorazepam HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0815-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["ALCOHOL PREP"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Dynarex Corporation"], "product_ndc": ["67777-121"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["3bdfc880-78a9-2f1b-e063-6394a90a1fe4"], "spl_set_id": ["39b20f1b-8d2f-4fa0-8cb9-10cad408e064"], "package_ndc": ["67777-121-14", "67777-121-19", "67777-121-20", "67777-121-16", "67777-121-17", "67777-121-18", "67777-121-13", "67777-121-11", "67777-121-12", "67777-121-27", "67777-121-26", "67777-121-21", "67777-121-22", "67777-121-23", "67777-121-24"], "is_original_packager": [true], "upc": ["0840117333307", "0840117333321", "0840117333345"], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1326-2022", "product_description": "Sterile Alcohol Prep Pads, Sterile, Latex Free, 100 large pads per box, manufactured for: Dynarex Corporation, NY 10962, NDC 67777-121-16.", "product_quantity": "10 boxes", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "Part# 1116", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67080", "recalling_firm": "Zions RX Formulations Services LLC dba RX Formuations Serv.", "address_1": "5949 E University Dr", "address_2": "N/A", "postal_code": "85205-7435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "AZ", "recall_number": "D-1217-2014", "product_description": "Sodium Bicarbonate 8.4%, a) 10 mL, b) 20 mL, and c) 22 mL units, Not for Dispensing, For Hospital Administration Only, Rx Formulations, 5949 East University Drive, Mesa, AZ 85205", "product_quantity": "610 units", "reason_for_recall": "Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.", "recall_initiation_date": "20131212", "center_classification_date": "20140407", "termination_date": "20140501", "report_date": "20140416", "code_info": "a) Lot #: 117460@5 Expiration Date: 12/12/2013, Lot #: 117911@5 Expiration Date: 12/19/2013, Lot #: 118301@9 Expiration Date: 12/25/2013   b) Lot #: 117462@6 Expiration Date: 12/12/2013, Lot #: 117916@6 Expiration Date: 12/19/2013, Lot #: 118305@10 Expiration Date: 12/25/2013   c) Lot #: 118011@23 Expiration Date: 12/18/2013, Lot #: 118092@63 Expiration Date: 12/18/2013, Lot #: 118401@31 Expiration Date: 12/25/2013,    Lot #: 118013@24 Expiration Date: 12/18/2013, Lot #: 118094@64 Expiration Date: 12/18/2013, Lot #: 118403@32 Expiration Date: 12/25/2013"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0092-2016", "product_description": "GLUTATHIONE  MDV, Injectable Solution, 200 mg/mL, syringe sizes: 60 mL, 90 mL; 100 mL; and 150 mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 (60mL) syringe, 3 (90mL) syringe, 5 (100mL) syringe, 1 (150mL) syringe", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12012014@6, t09182014@28, t09162014@31, t09162014@22, t08292014@6, t08122014@26, t07222014@15, t05262015@13, t01192015@11, t05082015@4, t04202015@13"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0058-2020", "product_description": "Human Chorionic Gonadotropin 5,000 Units/Vials Lyophilized For SC/IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC03321673964", "product_quantity": "2219 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92164", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, TX", "recall_number": "D-0562-2023", "product_description": "Seatex Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-Sterile Solution Net Contents: 3.785 L (1 Gallon) Container, UPC 6 12592 01480 0 Seatex, LLC. 445 TX Hwy 36 Rosenberg, TX 77471.", "product_quantity": "2880 containers", "reason_for_recall": "Superpotent Drug and Failed Impurities/Degradation Products: formula does not adhere to the labeled specifications", "recall_initiation_date": "20230419", "center_classification_date": "20230503", "report_date": "20230510", "code_info": "Lot: 220888, Exp. 05/20/2023", "more_code_info": ""}, {"country": "United States", "city": "Roseville", "address_1": "8303 Sierra College Blvd Ste 128", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin", "address_2": "", "product_quantity": "", "code_info": "All lots and package sizes", "center_classification_date": "20170711", "distribution_pattern": "Nationwide via internet", "state": "CA", "product_description": "ZRECT for Women Herbal Dietary Supplement Capsules, 500 mg, supplied in 30 count packages, Distributed by Organic Herbal Supply, Roseville, CA --- UPC Code 680474229055", "report_date": "20170719", "classification": "Class I", "openfda": {}, "recalling_firm": "Organic Herbal Supply", "recall_number": "D-0970-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77055", "termination_date": "20180309", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "95661-9420", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0928-2019", "product_description": "NET Remedies #11 (Lilac Label) Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "599 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-072018C Exp. 07/20; AUS-100117D Exp. 10/19"}, {"status": "Terminated", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74591", "recalling_firm": "Vital Care Compounder, LLC", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS", "recall_number": "D-1166-2016", "product_description": "TESTOSTERONE CYPIONATE 200mg/ml, 1ML MDV, Vital Care Compounder, Hattiesburg, MS", "product_quantity": "13 units", "reason_for_recall": "Lack of Assurance of Sterility:  Aluminum crimps do not fully seal the rubber stopper to the vial on all containers.", "recall_initiation_date": "20160629", "center_classification_date": "20160707", "termination_date": "20161031", "report_date": "20160713", "code_info": "Lot#:382331, Use by 12-11-16"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92248", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0566-2023", "product_description": "Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles.", "product_quantity": "Pending", "reason_for_recall": "CGMP deviation: product outside labeled storage temperature requirements.", "recall_initiation_date": "20230331", "center_classification_date": "20230504", "report_date": "20230510", "code_info": "SKUs a) 0999841; b) 0916071 stored and distributed from DCs 07/28/2022 through 03/31/2023.", "more_code_info": ""}, {"country": "United States", "city": "Windsor", "address_1": "755 Rainbow Rd Ste B", "reason_for_recall": "Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.", "address_2": "", "product_quantity": "196 bags", "code_info": "Lot # 20180328@25, Exp 06/26/2018", "center_classification_date": "20180702", "distribution_pattern": "Product was distributed throughout the United States.", "state": "CT", "product_description": "Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag (320 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT", "report_date": "20180711", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals, LLC", "recall_number": "D-0905-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80303", "termination_date": "20190204", "more_code_info": "", "recall_initiation_date": "20180614", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Westbury", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77007", "recalling_firm": "P & L Development,  LLC", "address_1": "200 Hicks St", "address_2": "", "postal_code": "11590-3323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0694-2017", "product_description": "Allergy Relief Diphenhydramine HCl 25 mg, Antihistamine, Dye-Free, 24 Softgels, distributed under the following labels: (a) TopCare Allergy Relief, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELK GROVE VILLAGE, IL 60007, NDC 36800-483-24, UPC 0-36800-39134-5; (b) Rexall Since 1903 Allergy Relief, PACKAGED FOR DOLGENCORP, LLC, 100 MISSION RIDGE GOODLETTSVILLE, TN 37072, UPC 3-59726-72025-0; (c) HyVee health Allergy Relief, DISTRIBUTED BY HY-VEE, INC. 5820 WESTOWN PARKWAY, WEST DES MOINES, IA 50266, NDC 42507-483-24, UPC 0-75450-12369-2; (d) up & up allergy relief, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-720-24, UPC 3-59726-72025-0; (e) smart sense allergy softgels, Distributed by Kmart Corporation, Hoffman Estates, IL 60179, NDC 49738-483-24, UPC 8-83967-39839-3.", "product_quantity": "369,012 cartons", "reason_for_recall": "Subpotent:  This product is being recalled due to low out of specification assay results at the 9 month time point.", "recall_initiation_date": "20170417", "center_classification_date": "20170502", "termination_date": "20190618", "report_date": "20170510", "code_info": "Lot #: a) A01542, A03660, A04300, A04930, Exp 03/19; A05484, A07951, A12448, Exp 07/19; Y93105, Exp  02/19; b) A04938, Exp 03/19; A08149, A12621, Exp 07/19; c) A06557, A13030, Exp 03/19; d) A00239, Exp 03/19; A05180, A09906, Exp 07/19; Y83246, Y87531, Y87680, Exp 08/18; Y91225, Y92670, Y98200, Y98674, Exp 02/19;  A13354, Exp 07/19; e) A07871, A11374, Exp 03/19; A14370, A18467, Exp 07/19.", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213803"], "brand_name": ["SUNITINIB MALATE"], "generic_name": ["SUNITINIB MALATE"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-901", "42291-902", "42291-903", "42291-904"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUNITINIB MALATE"], "rxcui": ["616279", "616285", "616289", "1541890"], "spl_id": ["0772f635-a03d-3c10-e063-6294a90a67ad"], "spl_set_id": ["0772eb61-ca42-39de-e063-6294a90a6632"], "package_ndc": ["42291-901-28", "42291-902-28", "42291-903-28", "42291-904-28"], "original_packager_product_ndc": ["0093-8199", "0093-8224", "0093-8229", "0093-8231"], "unii": ["LVX8N1UT73"]}, "product_type": "Drugs", "event_id": "95596", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0104-2025", "product_description": "Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.  NDC 42291-902-28", "product_quantity": "20 bottles", "reason_for_recall": "Labeling: Label Mix-Up", "recall_initiation_date": "20241018", "center_classification_date": "20241204", "report_date": "20241211", "code_info": "Lot #: 100049501, Exp. Date 07/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86361", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in CA, IN, VA, NJ, NY, RI, FL, TX, MO, PA, MI, AL, TN, SC", "recall_number": "D-1628-2020", "product_description": "Eye Itch Relief, Ketotifen Fumarate Ophthalmic Solution 0.035%, Sterile, 5 mL, Distributed by CVS Pharmacy, Inc. Woonsocket, RI 02895, NDC 59779-920-01", "product_quantity": "25,843 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20200903", "center_classification_date": "20200930", "termination_date": "20220801", "report_date": "20201007", "code_info": "Lot 8A11A exp 12/20"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201720"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-015", "62756-017", "62756-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["bf24bb84-d12f-44e7-98bd-46f3aa792bcc"], "spl_set_id": ["3653a602-4551-4e6c-84a7-31861f5dc482"], "package_ndc": ["62756-017-40", "62756-015-40", "62756-016-40"], "is_original_packager": [true], "upc": ["0362756017405", "0362756015401", "0362756016408"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "84672", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0788-2020", "product_description": "Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10 mL Multiple Dose Vial (NDC 62756-016-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals, Industries, Ltd., Gujarat, India", "product_quantity": "", "reason_for_recall": "cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.", "recall_initiation_date": "20200114", "center_classification_date": "20200116", "termination_date": "20200831", "report_date": "20200122", "code_info": "a)  JKT0075A, JKT0076A, JKT0213A, JKT0215A, JKT0369A, JKT0214A, JKT0368A, JKT0370A exp Jan-20;  JKT0371A, JKT0515A, JKT0514A, JKT0516A, JKT0518A, JKT0517A, JKT0694A, JKT0695A, JKT0696A, exp Feb-20;  JKT0697A, JKT0698A, JKT1063A, JKT1064A, JKT1065A, JKT1148A, JKT1068A, JKT1146A, JKT1066A exp Mar-20;  JKT1149A, JKT1147A, JKT1150A, JKT1427A, JKT1428A, JKT1426A, JKT1429A, JKT1540A, JKT1539A, JKT1541A, JKT1543A, JKT1542A exp Apr-20;  JKT1725A, JKT1574A, JKT1727A, JKT1863A, JKT1864A, JKT1865A, JKT1726A  exp May-20;  JKT2191A exp Jun-20;  JKT1866A, JKT2192A, JKT2193A, JKT2194A, JKT2575A, JKT2195A, JKT2576A  exp Jul-20;  JKT2578A, JKT2579A, JKT2911A, JKT2907A, JKT2908A, JKT2909A, JKT2910A, JKT2577A exp  Aug-20;  JKT3104A, JKT3105A, JKT3106A, JKT3260A, JKT3261A, JKT3263A, JKT3107A, JKT3467A, JKT3262A, JKT3264A exp Sep-20;  JKT3788A, JKT3468A, JKT3749A, JKT3469A, JKT3787A  exp Oct-20;  JKT3790A, JKT4019A, JKT3789A, JKT4016A, JKT4014A, JKT4017A, Nov-20;  JKU0040A exp Dec-20;  JKU0041A, JKU0042A, JKU1043A, JKU1044A exp Feb-21;    b)   JKT1862A, JKT1578A exp May-20;  JKT2000A, JKT1999A, JKT2001A exp Jun-20;  JKT2593A, JKT2594A exp Jul-20;  JKT3863A, JKT4013A exp Nov-20;  JKU0037A, JKU0038A, JKU0358A exp Dec-20", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Phenylephrine HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0825-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-670-2015", "product_description": "Ezetimibe active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0724-2020", "product_description": "CLON 750MCG/MORP 30MG/SUF 37.5MCG/ML in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@21 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77780", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1072-2017", "product_description": "Norepinephrine Bitartrate 4 mg Added to 0.9% Sodium Chloride 250 mL  (16 mcg per mL) Single-Dose Bag, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-134-18", "product_quantity": "3039 bags", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20170714", "center_classification_date": "20170809", "termination_date": "20200916", "report_date": "20170816", "code_info": "Lot #: 10069, BUD: 7/24/2017; 10090, BUD: 7/26/2017; 10121, BUD: 7/31/2017; 10142, BUD: 8/3/2017; 10183, BUD: 8/8/2017; 10360, BUD: 8/31/2017; 10443, BUD: 9/14/2017"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83378", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was shipped to wholesalers throughout the United States.", "recall_number": "D-1515-2019", "product_description": "Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count (NDC 67877-0514-05) bottles, Rx only, Manufactured by: Alkem Laboratories, Ltd, Mumbai INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ", "product_quantity": "a) 5,472 bottles and b) 5,880 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20190719", "center_classification_date": "20190724", "termination_date": "20210607", "report_date": "20190731", "code_info": "a) Lot# 19140443, exp. date 12/2020, Lot# 19140525, 19140535, exp. date 01/2021 and   b) Lot# 19140756, exp. date 12/2020, Lot# 19140757, Lot# 19140758, exp. date 01/2021, Lot# 19141696, Lot# 19141793, exp. date 03/2021"}, {"country": "United States", "city": "Paramount", "address_1": "16101 Garfield Ave", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found Rhino 5 which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine.  Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug.  Dapoxetine is an active ingredient not approved by", "address_2": "", "product_quantity": "2,395 blister packs total for all products", "code_info": "Lot #: KWAKPMC030505175957019, Exp 12/16", "center_classification_date": "20140130", "distribution_pattern": "CA", "state": "CA", "product_description": "Rhino 5 capsules(Spanish & English Labeling), 1 capsule per blister pack, Distributed by P&A Enterprise, Buena Park, CA  90621, English UPC 6 10708 10730 9, Spanish UPC 6 10708 10729 3.", "report_date": "20140205", "classification": "Class I", "openfda": {}, "recalling_firm": "SS Wholesale Inc. dba Jobbers Wholesale", "recall_number": "D-1045-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66840", "termination_date": "20140509", "more_code_info": "", "recall_initiation_date": "20131118", "postal_code": "90723", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-779-2015", "product_description": "Mepivacaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-118-2013", "product_description": "Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "10,865 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "San Marcos", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77660", "recalling_firm": "HARDCORE FORMULATIONS", "address_1": "3012 Fm 621 Ste B", "address_2": "N/A", "postal_code": "78666-1668", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1084-2017", "product_description": "ULTRA-STEN Rapid Size and Strength capsules, 10 mgs, 90 count bottle, Hardcore Formulations UPC: 7 48252 68763 0", "product_quantity": "1490 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine.", "recall_initiation_date": "20170705", "center_classification_date": "20170814", "termination_date": "20201005", "report_date": "20170823", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83581", "recalling_firm": "Aurolife Pharma, LLC", "address_1": "2400 US Highway 130", "address_2": "N/A", "postal_code": "08810-1519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1865-2019", "product_description": "Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b) 30-count cartons (NDC 60000-409-30); c) 45-count bonus cartons (NDC 60000-409-48); d) 45-count cartons (NDC 60000-409-45); CAREone, Distributed by: Foodhold U.S.A., LLC, Landover, MD 20785.", "product_quantity": "a) 9662 cartons; b) 7382 cartons; c) 5184 cartons; d) 9842 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190823", "center_classification_date": "20190917", "termination_date": "20220816", "report_date": "20190925", "code_info": "Lot #s: a) 067180025D1, Exp 07/21; b) 067180025B1, Exp 07/21; c) 067180025A1, Exp 07/21; d) 067180025C1, Exp 07/21"}, {"status": "Terminated", "city": "Verna, Salcette, Goa", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA078043"], "brand_name": ["AMLODIPINE BESYLATE"], "generic_name": ["AMLODIPINE BESYLATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-233", "68180-750", "68180-751", "68180-752", "68180-719", "68180-720", "68180-721", "68180-455"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE"], "rxcui": ["197361", "308135", "308136"], "spl_id": ["63bc4df8-5e26-45dd-8a05-78ee94553129"], "spl_set_id": ["003dd1ec-16f8-4f96-b6a8-c4689d35892a"], "package_ndc": ["68180-750-09", "68180-751-09", "68180-751-03", "68180-751-17", "68180-752-09", "68180-752-03", "68180-719-03", "68180-719-09", "68180-720-09", "68180-720-03", "68180-721-03", "68180-721-09", "68180-233-01", "68180-233-02", "68180-455-02", "68180-455-01"], "is_original_packager": [true], "unii": ["864V2Q084H"]}, "product_type": "Drugs", "event_id": "74964", "recalling_firm": "Lupin Limited", "address_1": "15-B, Phase 1A, Verna Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US      No recalled product was distributed to any foreign consignees by Lupin.", "recall_number": "D-1493-2016", "product_description": "Amlodipine Besylate Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-752-03", "product_quantity": "11,812 bottles", "reason_for_recall": "CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.", "recall_initiation_date": "20160219", "center_classification_date": "20160906", "termination_date": "20170403", "report_date": "20160914", "code_info": "Lot #: G304677, G304540, G304536,  G304537, G304535, G304541,  G304545, G304533, G304532, G304539, G304538, G304534,  Exp. 4/2016", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "80 bags", "code_info": "Lot: 169170", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Calcium Chloride 1 g/50 mL* Added to 5% Dextrose (20 mg/mL)*, Single-Dose Bag, Rx Only, Hospital/Office Use Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-175-37", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0184-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-788-2015", "product_description": "Methscopolamine Bromide Combo active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "10 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0147-2015", "product_description": "Tri-mix, 15 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "5 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08132014@35, Exp 11/11/2014", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1368-2022", "product_description": "Listerine Cool mint Mouthwash 250 mL SKU 900733  Crest Scope Outlast Mint Mouthwash 1 Liter SKU 902704  Swan Mouthwash Green Mint 1 LTR SKU 908114  Colgate Peroxyl Antiseptic Mouth Sore Rinse 8.4 FL OZ SKU 998273  Listerine Cool Mint Mouthwash 50.72 FL OZ SKU 999050  Swan Spring Mint Antiseptic Mouth Rinse 8.5 OZ SKU 900273  Swan Original Antiseptic Mouth Rinse 8.5 OZ SKU 900938  Colgate Optic White Mouthwash 16 FL OZ SKU 999043  Crest Scope Classic Original Min Mouthwash 1 Ltr SKU 908109  Listerine Cool Mint Mouthwash 500 mL SKU 908223  Act Kids Bubble Gum Blowout Mouthwash 16.9 Fl OZ SKU 999935  Swan Ice Mint Antiseptic Mouth Rinse 8.5 OZ SKU 903150  Swan Mouthwash Cool Mint 1 Liter SKU 908466  Crest Mouthwash Pro Health Multi Protection Mint 1 Liter SKU 908123,  Colgate Mouthwash Total Advanced Peppermint Blast 1 Liter SKU 903156  Listerine Total Care Freshmine 1 Liter SKU 900980  Listerine Ultra Clean Cool Mint 1 Liter SKU 901904  Listerine Mouthwash Freshburst 1 Liter SKU 903159  Listerine Mouthwas Original Amber 1 Liter SKU 908004  Listerine Mouthwash Coolmint 1 Liter SKU 908005  Swan Antiseptic Rinse Amber 1 Liter SKU 908465  Crest Scope Mouthwash All Day 1 Liter SKU 998269  Listerine Mouthwash Coolmint 95 Milliliters SKU 999752  Swan Fresh Mint Mouthwash 1 Liter SKU 999762   distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown.", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 900733; 902704; 908114; 998273; 999050; 900273; 900938; 999043; 908109; 908223; 999935; 903150; 908466; 908123; 903156; 900980; 901904; 903159; 908004; 908005; 908465; 998269; 999752; 999762", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0822-2023", "product_description": "Lidocaine Ointment USP, 5%, 1 1/4 oz tubes, Rx Only, Manufactured for: HI-TECH PHARMACAL CO., INC., Amityville, NY 11701.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020983"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Prasco Laboratories"], "product_ndc": ["66993-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123076"], "spl_id": ["900ad6e1-b46b-47e4-90e5-80cd44a42e40"], "spl_set_id": ["b25d9d6b-eb4c-452e-89ef-10e611deebd6"], "package_ndc": ["66993-019-68"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0162-2024", "product_description": "ALBUTEROL SULFATE HFA Inhalation Aerosol, 90MCG per actuation, 200 Metered Inhalations, Net Wt. 18 g, Rx Only, Manufactured for: Prasco Laboratories, Mason, OH 45040 USA.  NDC: 66993-019-68", "product_quantity": "2 cartons", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch MY7E", "more_code_info": ""}]